Enovis (ENOV) FCF Payout Ratio Growth (1y) (2013 - 2014)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 9.00% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -67.77% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -7.45% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -51.96% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 9,472.45% |
| 10 | Enovis | 1.25 Bn | 1.22 Bn | 365.49 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2014 | 69.78% |
| Dec 31, 2013 | -72.78% |
| Sep 27, 2013 | -87.93% |
| Jun 28, 2013 | 460.84% |
| Mar 29, 2013 | -895.32% |